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Abstract  
 
Background: Duchenne muscular dystrophy (DMD) is caused by a defective gene located on the X-chromosome, 
responsible for the production of the dystrophin protein. Complications in the musculoskeletal system have been 
previously described in DMD patients. Whole body vibration exercise (WBVE) is a treatment that improves 
musculoskeletal function in movement disorders. The aim of this study was to review the effects of WBVE on 
functional mobility, bone and muscle in DMD patients.  
Materials and Methods: Four databases were searched. Three eligible studies were found; all three conclude the 
management of DMD patients with WBV was clinically well tolerated. The studies used a side-alternating WBV 
system, frequencies 7 - 24 Hz; and amplitudes 2 - 4 mm.  
Results: A work indicates that a temporary increase in creatine kinase in DMD during the first days of WBV was 
observed, but other authors did not find changes. No significant changes in bone mass, muscle strength or bone 
markers. Some patients reported subjective functional improvement during training. Interpretation:  
Conclusion: It is concluded that WBV seems to be a feasible and well tolerated exercise modality in DMD patients. 
 
Keywords: whole body vibration exercise, Duchenne muscular dystrophy, rehabilitation. 
 
Introduction 
 
 Muscular dystrophy (MD) is an inherited group of degenerative disorders resulting from modifications in 
genes responsible for normal muscle function (Emery, 2002) and in which progressive muscle weakness is the main 
primary symptom (Flanigan, 2012). Duchenne muscular dystrophy (DMD) for example is caused by a defective gene 
located on the X-chromosome which is responsible for the production of a muscular protein, namely dystrophin 
(Hoffman, 1987;Ervasti,1990; Worton, 1995). This protein plays an important role in preventing muscle fatigue 
(Sander, 2000; Kobayashi, 2008; Allen et al. 2010). It has important functions related to cellular permeability of the 
sarcolemma(Rybakova, 2000; Goldstein, 2010) and protects dystrophin-associated proteins, including neuronal nitric 
oxide synthase (nNOS) (Lai, 2009). This in turn is important in the production of nitric oxide (NO) (Brenman, 1995) 
which regulates vasodilation and increases blood flow into muscle (Hellsten, 2012).  
 DMD affects only males (Strehle, 2015). Signs of myopathy may be detected from birth through laboratory 
findings although the clinical sign usually occurs later between two and three years of age(Gardner-Medwin, 1980; 
McDonald, 2012). Creatine kinase (CK) blood levels are often utilized as diagnostic markers for DMD (Cacchiarelli, 
2011). Serum CK concentrations are elevated in these patients and usually exceed 1000 IU/L and can be as high as 30 
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000 IU/L (Strehle, 2015). CK levels however are a poor indicator of disease progression and are not routinely measured 
once the diagnosis has been established (Strehle, 2015). Mirski and Crawford (2014) have described that children with 
DMD might have different degrees of mild cognitive impairment or global developmental delay. However, they may 
also have average or above-average intelligence.  
 Muscle weakness and decreased muscle functioning affects normal bone growth and development. Back 
pain and fractures involving the long bones and vertebrae are frequently seen in boys with DMD due to decreased bone 
mineral density (BMD) (Morgenroth, 2012). In another study of 378 participants with DMD (ranging from one to 25 
years of age), 21% were reported to have had fractures due to falls (McDonald, 2002). Another frequently reported 
secondary impairment in especially the non-ambulant child with DMD is scoliosis (Hsu, 2013; Canavese, 2014). The 
progressive weakness of the paraspinal muscles leads to trunk and body positional changes that facilitate the 
development of a progressive collapsing scoliosis. Scoliosis interferes with comfortable sitting and affects pulmonary 
function(Canavese, 2014). These children’s quality of life decreases over time and many suffer acute respiratory failure 
(Mangera, 2012). 
 Authors have reported that the optimum management of DMD requires a multidisciplinary approach and 
should focus on anticipatory and preventive measures as well as active interventions to address the primary and 
secondary aspects of the disease (Bushby 2010). Corticosteroids are also prescribed and have shown to prolong 
ambulation, however, given their effect on bone health may not be the best treatment intervention in this population 
(Morgenroth, 2012). 
 Exercise is a well-evidenced non-pharmacological treatment approach to improve bone mineral density 
(BMD) (Caulton, 2004). There is even some evidence to suggest that regular standing programs may have a positive 
effect on bone (Caulton, 2004). A Consensus Guideline document by Bushby et al. (2010) recommends that all boys 
with DMD who are ambulatory or in the early non-ambulatory stage participate in regular sub maximum exercise to 
avoid disuse muscle atrophy and other complications of inactivity. The guideline also recommends that low-resistance 
strength training and optimization of upper body function may provide additional benefits. Nevertheless, it also warns 
against over-activity as this can result in pain and myoglobinuria which in turn increases fatigue in the muscle (Bushby, 
2010). Therapists and exercise professionals are thus challenged to find the delicate balance between activity and over-
activity when designing exercise training programs for this population, and whole body vibration (WBV) could be a 
reliable option (Sanudo, 2010; Santos-Filho, 2012; Collado-Mateo, 2015). 
 WBV is increasingly being recognized as a useful mode for increasing strength and improving 
neuromuscular function (Sanudo, 2010;Santos-Filho, 2012; Collado-Mateo, 2015). WBV may be performed when a 
person either stands stationary or performs movements while standing, sitting or lying on an oscillating/vibratory 
platform (OVP) (Cochrane, 2010; Rittweger, 2010). The reported benefits of standing and/or exercising on an OVP 
include decreased joint compression, while still facilitating a contraction stronger than what is performed with the same 
exercise on dry-land (Rittweger, 2003; Cochrane, 2011; Boucher, 2015). A review published in 2010, however, pointed 
out that there is little scientific evidence supporting optimal vibration frequency and other treatment parameters to be 
used in the protocols involving WBV(Cochrane, 2010; Rittweger, 2010). Despite the lack of evidence this mode of 
exercise is increasingly being utilized in the DMD population (Soderpalm, 2013;Myers, 2014; Vry 2014). The use of 
WBV is increasing in populations with sub-optimal health such as, fibromyalgia (Sanudo, 2010; Collado-Mateo, 2015), 
cystic fibrosis (Roth, 2008; Maiworm, 2011), cerebral palsy (Sá-Caputo, 2015; Saquetto, 2015), osteogenesis imperfect 
(Semler, 2008) and multiple sclerosis (Jackson, 2008; Santos-Filho 2012). WBV exercise was firstly introduced (Hand, 
2009) to try to reduce the effects of zero gravity experienced by astronauts while in space(LeBlanc, 2000).  
 The effect of the mechanical vibration on the musculoskeletal system would produce changes in the length 
of the muscle tendon complex. Due to this situation, a tonic muscle contraction via the tonic vibration reflex can be 
elicited (Rittweger, 2003;Cochrane 2011). Boucher et al. (2015) reported that acute soleus muscle vibration interferes 
with plantar flexion torque generation by distorting proprioceptive information. However, high-frequency vibration 
applied on soleus muscle elicited higher force reproduction errors than low-frequency stimulation. In addition, 
Cochrane, 2010 and Rittweger, 2010 have pointed out that there is little scientific documentation about the appropriate 
vibration frequency, well as other parameters to be used in WBV protocols. Further research is recommended 
according to the recommendation for reporting WBV intervention studies of the International Society of 
Musculoskeletal and Neuronal interactions (Rauch, 2010). 
 Besides the desirable clinical effect of WBV, undesirable side effects have also been reported. In untrained 
participants exposed to acute vibration Crewther et al. (2004) reported problems like, hot feet, itching of the lower 
limbs, vertigo and severe hip discomfort and Cronin et al. (2004) reported pain of jaw, neck and lower limbs from acute 
intermittent WBV. Monteleone et al. (2007) reported a case of significant morbidity following one session of WBV in a 
patient with asymptomatic nephrolithiasis and Franchignoni et al. (2013) described that a healthy elite athlete suffered 
two episodes of hematuria after WBV training. 
 Putting together the findings reported, considering the relevance (Caulton, 2004; Bushby, 2010; Rittweger, 
2010; Sanudo, 2010; Soderpalm, 2013; Myers, 2014; Vry, 2014), the possible desirable effects of WBV(Crewther, 
2004; Cronin, 2004; Monteleone, 2007; Franchignoni, 2013) and the possibility of the use of this kind of exercise to 
manage DMD patient, is presented this investigation. The aim of this study was to systematically appraise published 
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research, in four databases, regarding the effects of exercise performed on a WBV on functional mobility, bone and 
muscle in DMD patients. 
 
Materials and Methods 
Search strategy 
 
Three reviewers independently accessed bibliographical databases available through the Universidade do 
Estado do Rio de Janeiro. Searches were performed using PubMed, Scopus, Science Direct and PEDro databases on 
August, 2015 with the main keywords (a) “Whole Body vibration” and “Duchenne muscular dystrophy”, (b) 
“Duchenne muscular dystrophy”, (c) “muscular dystrophy”, (d) Exercise and “Duchenne muscular dystrophy”, (e) 
"physical activity” and “Duchenne muscular dystrophy” and (f) “Whole Body vibration”. The number of publications 
(NP) was determined to each item searched in each database. About the databases used, briefly, (a) PubMed comprises 
more than 24 million citations for biomedical literature from MEDLINE, life science journals and online book 
(http://www.ncbi.nlm.nih.gov/pubmed), (b) Science Direct is a leading full-text scientific database offering journal 
articles and book chapters from nearly 2500 journals and more than 30000 books (http://www.sciencedirect.com), (c) 
PEDro is the Physiotherapy Evidence Database and it is a free database of over 29000 randomised trials, systematic 
reviews and clinical practice guidelines in physiotherapy. PEDro is produced by the Centre for Evidence-Based 
Physiotherapy at The George Institute for Global Health. (http://www.pedro.org.au) and (d) Scopus is the largest 
abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings. 
Delivering a comprehensive overview of the world's research output in the fields of science, technology, medicine, 
social sciences, and arts and humanities (http://www.elsevier.com/online-tools/scopus). 
As it is shown in Table 1, in general, in all the searches with selected keywords, the number of publications in 
the Science Direct database was higher than in the other databases. Nevertheless, the number of publications was the 
smallest in the PEDro database. The number of publications with the keywords “Duchenne Muscular Dystrophy” and 
“Muscular Dystrophy” is elevated. However, a small percentage of them although only is related to the WBV exercise 
independently on the database searched. 
 
Table 1: Number of publications in the PubMed, Scopus, Science Direct and PEDro databases 
Keywords PubMed Scopus PEDro Science Direct 
“Whole Body vibration” and “Duchenne 
muscular dystrophy” 
  
3 4  0 119 
“Duchenne muscular dystrophy”  
 
7,881 11,825 22 11,583 
“muscular dystrophy”  
 
20,507 460 33 36,739 
Exercise and “Duchenne muscular dystrophy” 
 
317 460 5 3191 
"physical activity” and “Duchenne muscular 
dystrophy” 
 
29 83 0 702 
“Whole Body vibration” 1,323 2,636 184 45,902 
 
Inclusion criteria 
 
To be included in this review, all studies had to investigate the effects of WBV in persons with DMD and had 
to comply with the following criteria: be a randomized controlled trial (RCT); in the absence of RCT’s, single group 
experimental studies were also considered (cross-over designs) and published in English. Studies were included if they 
enrolled participants with DMD who performed static or dynamic exercises on WBV. All three reviewers then read the 
126 abstracts of studies deemed potentially eligible independently and for those that continued to meet the inclusion 
criteria the full texts were accessed. Where consensus could not be reached a fourth team member was consulted. 
Duplicates were eliminated.  
The studies were independently appraised and the level of evidence of each one was classified according to the 
National Health and Medical Research Council hierarchy of evidence (NHMRC, 2009) (Merlin et al. 2009) (Figure 1). 
The methodological quality of the selected articles was evaluated following the PEDro scale (Morihisa, 2016). Briefly, 
each publication was evaluated according to: (a) eligibility criteria, (b) subjects were randomly allocated to groups, (c) 
concealed allocation, (d) the groups with baseline similarity, (e) blinding of the patients, (f) blinding of the therapists, 
(g) blinding of all assessors, (h) measures obtained from more than 85% of the subjects, (i) all subjects received the 
treatment or control condition or, at least one key outcome was analysed by “intention to treat”, (j) results of the groups 
with statistical comparisons and (h) point measures and measures of variability of outcome. Those publications with a 
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score of seven or greater in the PEDro scale were considered of ‘high’ methodological quality, those with a score of 
five to six would be of ‘fair’ quality and a score of four or below were classified as ‘poor’ quality(Walser, 2009). 
 
Figure 1. Level of Evidence adapted. 
Exclusion criteria 
 
 Papers were excluded if they were (a) published in a language different from English; (b) review articles; (c) 
replies; (d) editorials; (e) abstracts; (f) proposal of a protocol; (g) books or chapter of books or abstracts; (h) animals 
studies; (i) including healthy people; (j) including combined treatments; (k) guidelines; (l) lectures; (m) occupational 
approaches; (n) in combination with other therapeutic procedures; and (o) patients with other diseases.  
 A flowchart, based in the PRISMA analysis(Liberati 2009), was done to show the steps in the selection of the 
full papers analyzed in this revision, as well as the elimination of unwanted publication. (Figure 2) 
 
 
Figure 2. Flowchart indicating the steps to selected the full papers analysed in this revision. 
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Human Rights and Informed Consent 
 
This article contains no studies with human subjects. 
 
Data analysis 
 
As data were not comparable, no statistical analysis was possible and findings are summarized in a narrative form. 
 
Results 
 Figure 2 shows the search strategy results using PRISMA(Liberati 2009) to indicate how full papers were 
selected. One hundred twenty-six articles were found using the key words “Duchenne Muscular Dystrophy” and 
“whole body vibration”. Ten articles were screened and one hundred sixteen were excluded; reasons for exclusion: (a) 
not published in English, (b) reply, (c) including healthy persons, (d) including animal studies, (e) other techniques, (f) 
with combined techniques, (g) investigating occupational approaches, (h) editorials or letters, or (i) including other 
diseases. Three studies were finally included in this review. In table 2 depicts the type of platform, the subjects 
(number, sex, and age), the frequency and the amplitude used in the OVP used in these three studies. The level of 
evidence and the methodological quality is also shown. 
 
Table 2: Data on device of the oscillating/vibratory platform, number of subjects and frequency and amplitude or the 
peak to peak displacement of the vibration 
Reference Level of 
evidence 
(LE) 
PEDro 
Scale 
score 
(quality) 
Platform 
Devices 
Number of 
subjects/sex/age 
Frequency(Hz) Amplitude 
(mm)/PtPD 
(mm)(Rauch 
2010) 
Vry et al, 
2014 
IV 5 (fair) side-
alternating  
n=22 (14 children with 
DMD/boys/mean 8.8 
years and 8 children with 
SMA/5girls, 3boys/mean 
9.9 years) 
15-18/ 18-24 4 
Soperpalm 
et al, 2013  
IV 4 (poor) side-
alternating 
n=6 (5.7 – 12.5 years, 
mean age of 6.8 years) 
16-24 2/4(PtPD) 
Myers et al, 
2014 
IV 4 (poor) side-
alternating 
n=4 (mean age of 10 
years) 
7-20 Not informed 
DMD – Duchenne muscular dystrophy, SMA – Spinal muscular atrophy, PtPD- peak-to-peak displacement. 
 
 All three studies included were Level of Evidence IV according to the NHMRC (Merlin 2009) and 
according to PEDro scale one study was of “fair” quality (score 5)(Vry 2014) and two were “poor” quality (score 
4)(Soderpalm 2013, Myers 2014). The range of frequency of the vibrations generated in the OVP used was 7 to 24 Hz 
and amplitude was 2 to 4 mm. In one study the amplitude and the peak to peak displacement were not defined(Myers 
2014). In total twenty four children with DMD participated in these investigations. Vry et al, 2014 (Vry 2014) studied 
twenty two patients, but only fourteen with DMD. The age varied from 4(Myers 2014) to 16 years(Vry 2014). All three 
studies used a side alternating OVP. 
 Table 3 shows the aim of the investigation, the protocol that was used, the findings and the conclusion of 
each analyzed full papers. Although, the investigations presented have aims with different approaches, all these papers 
present conclusions indicating the importance of WBV to improve and/or maintain clinical conditions that are relevant 
to the patient with DMD. Authors used different tools to evaluate the effect of WBV. Vry et al, 2014(Vry 2014) used 
the 6-min walking distance, 10 m walking time, time to climb 4 stairs, time to rise from supine, Medical Research 
Council Scale to examine muscle strength, myometry knee sum score, myometry elbow flexors, angle degree of 
dorsiflexion of the right ankle, and CK levels. Soderpalm et al, 2013, analyzed BMD and bone mineral content for total 
body, total hip and lumbar spine. Bone mass was performed using the dual-energy X-ray absorptiometry (DXA) and 
laser (DXL) Calscan technique. Biomarkers of bone and mineral metabolism (serum sclerostin, serum bone-specific 
alkaline phosphatase, serum osteocalcin insulin-like growth factor-I, insulin-like growth factor binding protein-3 and 
CK) were determined. Myers et al, 2014 measured the CK levels and functional mobility through North Star 
Ambulatory Assessment Score.  
 Vry et al, 2014 have reported a temporary increase in CK in DMD during the first days of WBV. 
Nevertheless, Soperpalm et al, 2013 did not find changes in CK activity, and no significant changes in bone mass, 
muscle strength or bone markers were found. Myers et al, 2014 observed a transient increase in CK, and some patients 
reported subjective functional improvement during the training period. In all the publications(Soderpalm 2013, Myers 
2014, Vry 2014) the management of DMD patient was considered clinically well tolerated. 
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Table 3: Aims, protocol, findings and conclusions identified in the selected papers involving DMD patients and WBV 
Reference Aim Protocol  Findings Conclusion 
Vry et al, 
2014. 
 
To evaluate the 
safety of WBV 
training in 
ambulatory 
children with 
DMD and 
SMA. 
Two consecutive days with 
2-3 training session per day 
in hospital. Between each 
training session, the patient 
had a break of at least 4 h. 
One training session 
consisted of 3 training units, 
each lasting 3 minutes, with 
a break of 3 minutes between 
each unit. After the teaching 
phase in the hospital, the 
patients continued with 
WBV training at home for 8 
weeks (4 week with 15-18 
Hz and 4 week with 18-20 
Hz). They followed by 
another 4 weeks without 
training. Primary outcome 
was safety of the training, 
assessed clinically and by 
measuring serum CK levels. 
Secondary outcome was 
efficacy as measured by 
changes in time function test, 
muscle strength and angular 
degree of dorsiflexion of the 
ankles. 
In boys with DMD, CK 
increased by 56% after the first 
day of training and returned to 
baseline after 8 weeks of 
continuous WBV training. No 
changes in laboratory 
parameters were observed in 
children with SMA. Secondary 
outcomes showed mild, but not 
significant improvements with 
the exception of the distance 
walked in the 6-min walking 
test in children with SMA, 
which rose from 371.3 m to 
402.8 m (p < 0.01). 
WBV training is 
clinically well 
tolerated in children 
with DMD and SMA. 
The relevance of the 
temporary increase in 
CK in DMD during 
the first days of 
training is unclear, but 
it is not related to 
clinical symptoms or 
deterioration. 
Soperpalm 
et al, 2013. 
 
To study the 
tolerability of 
WBV exercise 
in patients 
with DMD and 
its effects on 
muscle and 
bone. 
WBV was performed two to 
three times a week for three 
month. Motor function, 
muscle strength, bone mass 
and biomarkers of bone and 
mineral metabolism were 
analyzed before and after the 
WBV period at 0, 3, 6 and 
12 months.  
No changes in CK activity 
were found, indicating that the 
WBV exercise did not further 
damage the skeletal muscle. 
No significant changes in bone 
mass, muscle strength or bone 
markers were found. There 
was a non-significant trend for 
the bone formation marker, 
bone-specific alkaline 
phosphate, to increase after 
three months of WBV. The 
bone formation marker levels 
returned to baseline three 
months after discontinuing 
WBV. 
WBV therapy appears 
to be safe and well 
tolerated among 
ambulatory DMD 
patients. The potential 
benefits of WBV on 
bone and muscle in 
DMD remain to be 
elucidated. 
 
Myers et 
al, 2014. 
To evaluate the 
vibration 
therapy in 
patients with  
DMD. 
All patients participated in a 
4-week training period 
involving WBV sessions 
three time per week. Serum 
CK was measured, and 
adverse effects reviewed at 
each session with functional 
mobility assessed before and 
after the training period. 
No major changes in 
functional mobility in the 
DMD patients were found. 
One patient had a transient 
increase in CK during the 
study; but, levels of this 
enzyme were stable when 
comparing the pre-training and 
post training values. Some 
patients reported subjective 
improvement during the 
training period. 
Side-alternating 
vibration therapy is 
well tolerated in 
children with DMD 
and may have potential 
to improve or maintain 
functional mobility 
and strength in these 
patients. 
WBV - whole body vibration, DMD - Duchenne muscular dystrophy, SMA - spinal muscular atrophy, CK – creatine 
kinase. 
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Discussion 
  
 The relevance of WBV to treat patients with several diseases has been shown previously. However, it is 
observed that this modality of exercise is still poorly used to manage DMD patients, as verified by the small number of 
publications in four databases (PubMed, Scopus, Science Direct and PEDro). 
 The analysis of the information described in the selected full papers utilized in this investigation shows that 
WBV is considered clinically well tolerated in DMD patients and some patients reported subjective functional 
improvement. 
 An important number of publications involving “Duchenne muscular dystrophy” were found, but only a 
small percentage of these publications involves whole body vibration exercises independently. This finding is in 
agreement with Rittweger (2010), and Cochrane (2010) who pointed out that, although vibration exercise is broadly 
available, it seems that this exercise modality is still largely unknown to the scientific community.  
 The number of publications selected in this study involving the use of WBV exercise to treat patients with 
DMD was low, and their level of evidence were IV according to the NHMRC (Merlin, 2009). The methodological 
quality was “poor” or “fair” (Table 1). This is an important aspect that should make us call into question the obtained 
results is the methodological quality of the studies. Therefore, our findings demonstrate the necessity of further 
research with a higher methodological quality and level of evidence involving DMD and WBV exercise.  
 Mild exercise is recommended several times per week (ideally daily) for patients with DMD (Eagle, 2002; 
Bushby, 2010) in order to slow down the progress of the disease or to prevent its complications. WBV exercise, as a 
physical activity, seems to be safe and without impairment on the clinical condition of the DMD patient. The frequency 
of the vibrations generated of the OVP utilized was between 7 and 24 Hz. All authors of the investigations selected in 
this narrative revision (Soderpalm, 2013; Myers,  2014; Vry, 2014) have suggested that the conditions of the protocols 
are well tolerated by ambulatory patients with DMD. This fact would be highly relevant for the use of exercise in DMD 
rehabilitation without exacerbation of symptoms of the disease. Other authors have also shown that positive clinical 
findings after WBV have been obtained in patients with neuromuscular disease such as, (i) Parkinson with 3, 6 and 9 
Hz (Arias, 2009; Chouza, 2011), or (ii) fibromyalgia with 12.5 Hz (Maiworm, 2011).  
 Despite these encouraging findings reported in this current revision, the effects should be interpreted with 
caution due to the variability of the frequencies (between 7 and 24Hz). Future research should be performed to examine 
the dose-response relationship and optimal dosing regimen of WBV according to several other parameters, such as 
exercise type, status training on vibration training, and the use of external load during vibration exercise. Additional 
focus on frequency and peak-to-peak displacement of the mechanical stimulus would also aid in the elaboration of 
appropriate protocols.  
 The current study has some limitations that must be considered in the interpretation of the findings. Firstly, 
it was found a small number of publications involving WBV and DMD patients. Furthermore, caution should be taken 
when generalizing the results due to the methodological variations concerning the biomechanical parameters or the 
variability of the protocols used. In addition, although we tried to retrieve the articles involving WBV and DMD with 
the selected keywords, it is not sure that all studies on this topic have been identified, including articles that were not 
published in English and articles published in journals that were not indexed in the databases there were searched. In 
addition, the limited number of publications with high methodological quality (RCTs) must also be considered and this 
fact could of course affect the evidence of the findings. Therefore, studies with a higher methodological quality would 
be desirable. The clinical application of WBV to the patients is that it is especially not harmful and is safe for 
rehabilitation. 
 In conclusion, despite the limitations, it can be verified that the use of WBV exercise has proven to be safe 
and could be an important option in the rehabilitation of patients with DMD. Moreover, benefits, without clinical 
complication to the patient with DMD have been reported. WBV seems to be a feasible and well tolerated modality 
exercise modality to manage DMD patients. 
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